Hereditary angio-oedema is an uncommon autosomal dominant disorder associated with low serum concentrations of Cl esterase inhibitor. It presents as recurrent swelling of the face, limbs, gut wall, or upper airway and is associated with considerable morbidity and mortality. Acute attacks affecting the airway are best treated with infusion of fresh-frozen plasma. Long-term prevention of attacks with antifibrinolytics or androgens has often been unsatisfactory owing to poor disease control or unacceptable side effects.' Danazol (dosage 600 mg/day), an androgen derivative, has recently been used successfully in preventing attacks while causing few side effects. 1974 1975 1976 1977 1978 1979 1980 F (figure) . He had no side effects except mild alopecia.
Case 2-This patient, a brother of the man reported on above, was a 30-year-old plate-metal worker who had had repeated attacks of hereditary angio-oedema since aged 16. The daily symptom diary that he had kept from 1974 showed that he had had up to five attacks a quarter until danazol was started in May 1979 (figure). The dose was reduced gradually to 300 mg/week with no attacks and no side effects. Concentrations of Cl esterase inhibitor and C4 rose dramatically when danazol was started and dropped progressively to pretreatment values as the dose was reduced (figure).
Comment
Danazol was extremely effective in preventing attacks of hereditary angio-oedema in these cases. The protective effect was maintained even as the dose was reduced progressively from 600 mg/day towards 300 mg/week. Both patients were eventually able to do hard physical work, one on off-shore oil rigs.
The mode of action of danazol is not clear. Danazol increases concentrations of Cl esterase inhibitor and C4 within a few days of the start of treatment,2 and the concentrations seem to be directly related to the dose used,3 as shown in our cases. Complete disease control may be maintained, however, even as the concentrations fall back to pretreatment values as the dose is reduced.4 This may be either because danazol exerts an effect independent of the concentration of Cl esterase inhibitor or because only small increases in this concentration are necessary to prevent activation of the complement cascade.
Although danazol appears to have few side effects,2 nobody has taken it over a long period, as may be necessary for patients with hereditary angio-oedema. The minimum effective dose, which is probably less than 200 mg/day, should therefore be found for each patient. This may be arrived at by titrating it against the patient's symptoms rather than serum concentrations of Cl esterase inhibitor. Our cases show that symptom diaries are ideal for controlling the treatment of such a chronic disease. I report a case of infantile acne associated with transient increases in concentrations of luteinising hormone, follicle-stimulating hormone, and testosterone and postulate that these abnormalities were due to delay in maturation of the hypothalamic "gonadostat."
Case report
The boy (figure) was admitted aged 11 months with a four-week history of vomiting and a rash on the cheeks, present since the age of 6 weeks. Examination showed obvious recent weight loss and malar acne. Genitalia were normal, the testes size being 1-2 ml. The vomiting proved to be due to rumination.
A random plasma cortisol concentration was raised at 859 nmol/l (31-1 tg/1OO ml), thought to be consistent with stress. Bone age, determined radiologically, was about 1 year. An echoencephalogram and renal-adrenal ultrasound examination were normal. A skull x-ray film showed possible slight enlargement of the pituitary fossa. Random concentrations of luteinising and follicle-stimulating hormones at 13 months were raised at 5 4 U/I and 17-1 U/l respectively (normal values at this age <2-5 U/I and <2 U/i respectively). His rumination settled and he thrived, but he was readmitted at 15 months in view of the abnormal findings. The acne persisted despite treatment, but examination was otherwise normal, although penis
